Risks of transfusion

Southern Medical Journal

Volumn 104, Issue 11, 2011, Pages 762-769

  Squires, Jerry E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Transfusion; Transfusion reactions; Transfusion transmitted disease

Indexed keywords

DIURETIC AGENT;

ALLERGIC REACTION; ANAPHYLAXIS; BACTERIUM CONTAMINATION; BLOOD COMPATIBILITY; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; DYSPNEA; FEBRILE NONHEMOLYTIC TRANSFUSION REACTION; FEVER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; HYPOTENSION; INFECTION; INTRAVASCULAR HEMOLYSIS; POSTTRANSFUSION PURPURA; PURPURA; REVIEW; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION ASSOCIATED DYSPNEA; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION TRANSMITTED INFECTION; VIRAL CONTAMINATION; WEST NILE FLAVIVIRUS;

ACUTE LUNG INJURY; BLOOD GROUP INCOMPATIBILITY; BLOOD SAFETY; BLOOD TRANSFUSION; COMMUNICABLE DISEASES; FEVER; HUMANS; HYPERSENSITIVITY; HYPOTENSION; POPULATION SURVEILLANCE; RESPIRATORY TRACT DISEASES; RISK ASSESSMENT; UNITED STATES;

EID: 80155165201     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31823213b6     Document Type: Review

References (49)

1. US Biovigilance Network [AABB Web site]. Available at: http://www.aabb.org/programsservices/biovigilance. Accessed February 10, 2010.
2. Leiby D. Making sense of malaria. Transfusion 2007;47:1573-1577. (Pubitemid 47300626)
3. Gubernot DM, Lucey CT, Lee, KC, et al. Babesiosis infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infects Dis 2009;48:25-30.
4. Williams AE, Orton SL. ''There's something about blood'': a scientific perspective on blood donor qualification, in Stramer SL (ed). Blood Safety in the New Millennium. Bethesda, MD, American Association of Blood Banks, 2001:1-32.
5. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA 1997;277:967-972. (Pubitemid 27142363)
6. Kleinman S, Busch MP. General overview of transfusion transmitted infections, in Petz LD, Swisher SN, Kleinman S, et al (eds). Clinical Practice of Transfusion Medicine. New York, Churchill-Livingstone, 1996.
7. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acidamplification testing. N Engl J Med 2004;351:760-768.
8. Busch MP. Closing the window on viral transmission by blood transfusion, in Stramer SL (ed). Blood Safety in the New Millennium. Bethesda, MD, American Association of Blood Banks, 2001.
9. Busch MP, Glynn SA, Stramer SL, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-264. (Pubitemid 40180144)
10. Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med 1992;327:419-421.
11. Bihl F, Castelli D, Marincola F, et al. Transfusion-transmitted infections. J Transl Med 2007;5:1-11.
12. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49:1SY29S.
13. Park YA, Brecker ME. Bacterial contamination of blood products, in Simon TL, Snyder EL, Solheim BG, et al (ed). Rossi's Principles of Transfusion Medicine. Chichester, UK, Wiley-Blackwell, 2009.
14. Hillyer CD, Josephson CD, Blajchman MA, et al. Bacterial contamination of blood products: risks, strategies, and regulation. Hematology 2003: American Society of Hematology Educational Program Book. Washington, DC: American Society of Hematology; 2003: 575-589.
15. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007;47:1134-1142.
16. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion, in Roback JD, Combs MR, Grossman BJ, et al (eds). AABB Technical Manual. Bethesda, MD, AABB, 2008.
17. Strauss RA, Gloster ES, Shanfield MS, et al. Anaphylactic transfusion reactions associated with a possible anti-A2m(1). Clin Lab Haematol 1983;5:371-377. (Pubitemid 14179745)
18. Shimada E, Tadokoro K, Watanabe Y, et al. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002;42:766-773.
19. Greenberger PA. Plasma anaphylaxis and immediate type reactions. in Rossi EC, Simon TL, Moss GS (ed). Principles of Transfusion Medicine. Baltimore, MD, Williams and Wilkins, 1991:635-639.
20. Sazama K. Reports of 355 transfusion-associated deaths: 1976-1985. Transfusion 1990;30:583-590.
21. Linden JV, Wagner K, Voytovich AE, et al. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000;40: 1207-1213.
22. Davenport RD. Hemolytic transfusion reactions, in Simon TL, Snyder, EL, Solheim BG, et al. Rossi's Principles of Transfusion Medicine. Chichester, UK, Wiley-Blackwell, 2009;811-825.
23. Bruno DS, Herman JH. Acute hypotensive transfusion reactions. Lab Med 2006;37:542-545.
24. Arnold DM, Hume HA. Hypotensive transfusion reactions, in Popovsky MA (ed). Transfusion Reactions. Bethesda, MD, AABB Press, 2007; 251-273.
25. De Rie MA, van der Plas-van Dalen CM, Engelfriet CP, et al. The serology of febrile transfusion reactions. Vox Sang 1985;49:126-134. (Pubitemid 15068173)
26. Heddle NM, Klama L, Singer J, et al. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-628. (Pubitemid 24276861)
27. Pomper GJ. Febrile, allergic, and nonimmune transfusion reactions. in Simon TL, Snyder EL, Solheim BG, et al. (eds). Rossi's Principles of Transfusion Medicine. Chichester, UK, Wiley-Blackwell, 2009:826-846.
28. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44:10-15. (Pubitemid 38177130)
29. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 774-789.
30. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med 2007;131:708-718. (Pubitemid 46726132)
31. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-462. (Pubitemid 36077563)
32. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. March 22, 2010. Available at: http://www.fda.gov/biologicsbloodvaccines/safetyavailability/reportaproblem/ transfusiondonationfatalities. Accessed February 21, 2011.
33. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009;49:1825-1835.
34. Chapman CE, Stainsby D, Jones H, et al. Serious hazards of transfusion steering group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009;49:440-452.
35. Eder AF, Herron RM, Strupp A, et al. Effective reduction of transfusionrelated acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010;50: 1732-1742.
36. Marriott HL, Kekwick A. Volume and rate in blood transfusion for the relief of anaemia. British Medical Journal 1940;1:1043-1046.
37. Zhou L, Giacherion D, Cooling L, et al. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion associated circulatory overload. Transfusion 2005;45:1056-1063. (Pubitemid 40935002)
38. Le G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009;49:13-20.
39. Bux J, Sachs UJH. Pulmonary transfusion reactions. Transfus Med Hemother 2008;35:337-345.
40. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763-771. (Pubitemid 29328491)
41. Schonewille H, van deWatering LMG, Brand A. Additional red blood cell alloantibodies after blood transfusion in nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006;46:630-635.
42. Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995;35:26-32.
43. McFarland JG. Posttransfusion purpura, in Papovsky MA (ed). Transfusion Reactions. Bethesda, MD, AABB Press, 2007:275-299.
44. Shulman NR, Aster RH, Leitner A, et al. Immunoreactions involving platelets. V. Post-transfusion purpura due to complement fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in autoimmunity. J Clin Invest 1961;40:1597-1620.
45. Shulman NR, Jordan JV. Platelet immunology, in Coleman RW, Hirsch J, Marder VJ, et al. (eds). Hemostasis and Thrombosis. Philadelphia, PA, Lippincott, 1982:247-342.
46. Dwyre DM, Holland PV. Transfusion-associated graft-versus-host disease. Vox Sang 2008;95:85-93. (Pubitemid 351951899)
47. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol 2002;117:275-287. (Pubitemid 34451142)
48. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993;33:742-750. (Pubitemid 23281646)
49. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273-282. (Pubitemid 44428107)